HEPATX CORPORATION
Blood test using mass spectrometry to detect donor hepatocyte proteins and measure success of hepatocyte transplantation
- Sector
- Medtech
- Total capital
- $700K
- Federal grants
- $700K
- 4 awards · 2017–2026
- Rank in peer group#18 of 95
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of a proteomic assay for monitoring transplanted cells and tissues$149K
- Federal grantHealth and Human S · Phase I · Development of a proteomic assay for monitoring transplanted cells and tissues$176K
- Federal grantHealth and Human S · Phase I · Development of a process to improve mesenchymal stromal cell banking at therapeutically relevant scale using transient telomere extension$225K
- Federal grantHealth and Human S · Phase I · Development of regenerative medicine therapies for liver failure$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 95 peers
Line = medianMedtech · Instrument
- Federal grants#18 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 6- PendingCell Therapy for Treating Liver DiseaseUSPTOApplication 19092716
- PendingMethods Of Tracking Donor Cells In A RecipientUSPTOApplication 18698329
- PendingNovel Compositions For Treating DiseaseUSPTOApplication PCTUS2025021816
Show all 6 patent records
- Cell Therapy for Treating Liver DiseaseOct 9, 2025 · Application 19092716Pending
- Methods Of Tracking Donor Cells In A RecipientMar 27, 2025 · Application 18698329Pending
- Novel Compositions For Treating DiseaseApplication PCTUS2025021816Pending
- Novel Compositions for Treating DiseaseApplication 63757013Pending
- Cell Therapy for Treating Liver DiseaseApplication 63574884Pending
- Methods Of Tracking Donor Cells In A RecipientApplication PCTUS2022077688Pending
Related companies, and why
- NEUROSONICS MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
- INFORMAI, INC.Similar federal contract value in Medtech · null in contracts
- AI-NEOTECH LLCSimilar federal contract value in Medtech · null in contracts
- FCS TECHNOLOGY, LLCSimilar federal contract value in Medtech · null in contracts
- BIOLATTICE, LLCSimilar federal contract value in Medtech · null in contracts
- XN HEALTH INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .